Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,483.0
10.7 (0.43%)

 

  • STI Straits Times Index
    2,483.0
    10.7 (0.43%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,511.7
    2.5 (0.17%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,476.0
    240.6 (1.04%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,217.5
    -1.9 (-0.06%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,511.6
    307.0 (1.32%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,906.5
    -39.2 (-0.79%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 764.8M
  • Value: 848.5M
  • Rise: 135
  • Fall: 143
  • Unch: 502

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.053+0.002
Vicplas Intl0.355-0.095
Sembcorp Marine0.143+0.001
OEL0.019+0.001
Singtel2.120-0.020
Synagie0.200-0.010
HPH Trust USD0.136+0.006
Oceanus^0.007-
QT Vascular0.007-
ThaiBev0.595+0.010

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

TOPGLOV TOP GLOVE CORPORATION BHD
Quotes 15 Minutes Delayed. Updated at 28 Sep 2020 16:59
Last (MYR): 8.770 Change: -0.030 High: 8.980 Remarks:
Change (%): -0.34 Low: 8.730
Open 8.900 Yesterday's Close 8.800
Buy Price 8.760 Sell Price 8.770
Buy Volume ('00) 1,072 Sell Volume ('00) 6,898
Cumulative Volume ('00) 532,190 Cumulative Value 470,181,372
Click to show Stock Prices chart

Latest News

View All News

Key Statistics

EPS (MYR) a 0.22962 Trailing EPS (MYR) e 0.22962 NAV (MYR) b 0.6136
PE a 38.194 Trailing PE f 38.194 Price / NAV b 14.2927
Dividend (MYR) d 0.118207 Cash In Hand (MYR) g 0.1489 Issued & Paid-up Shares c 8,130,820,000
Dividend Yield (%) d 1.348 Price / Cash In Hand g 58.899 Treasury Shares h 49,859,000
Beta - 75 Daysi 3.205 R-Squared - 75 Days(%)i 38.66 Market Cap (M) 71,307.291
Beta - 500 Daysi 1.314 R-Squared - 500 Days (%)i 15.82 Enterprise Value (M) 70,288.657
Piotroski F Score 8 Exchange Code 7113 Par Value ( MYR ) 0.50000
52 Weeks Volatility (%) 62.94 6-Month VWAP 6.476 Free Float (%) 30.0
Shariah Compliant Stocks Yes
Sector & Industry Health Technology - Medical Specialties
Index Components BM HEALTH CARE / FTSE Bursa Malaysia EMAS Index / FTSE Bursa Malaysia EMAS Shariah Index / FTSE Bursa Malaysia KLCI Index / FTSE Bursa Malaysia Top 100 Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 25 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 25 Sep 2020.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference TOPGLOV Bursa 71,307.291 38.194 38.194 14.2927 1.348
Industry HEALTH CARE EQUIPMENT & SERVICES Bursa 1,667.225 57.261 52.411 15.6980 0.743
Medical Specialties Bursa 38,671.808 54.650 52.307 16.5501 0.791
Index BM HEALTH CARE Bursa 13,626.785 61.411 69.752 6.2125 0.791
FTSE Bursa Malaysia EMAS Index Bursa 5,024.881 20.696 30.972 1.2997 3.375
FTSE Bursa Malaysia EMAS Shariah Index Bursa 4,822.228 34.093 54.724 1.7195 2.471
FTSE Bursa Malaysia KLCI Index Bursa 32,572.193 18.056 23.852 1.6333 3.517
FTSE Bursa Malaysia Top 100 Index Bursa 13,060.772 19.944 27.721 1.5252 3.210
Local Peer HARTA Bursa 60,399.321 139.293 107.772 22.2791 0.434
Local Peer SUPERMX Bursa 22,526.091 42.860 42.859 14.1998 -
Local Peer LKL Bursa 454.528 105.788 105.780 7.5177 -
Global Peer ABBOTT LABORATORIES NYSE 183,161.329 49.962 59.603 5.9900 1.270
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 167,053.279 45.198 45.076 5.5917 0.181
Global Peer DANAHER CORP NYSE 146,961.168 59.049 50.310 4.4542 0.322
Global Peer MEDTRONIC PLC NYSE 138,669.735 28.956 31.430 2.7571 2.089
Global Peer INTUITIVE SURGICAL INC NASDAQ 78,843.927 57.162 69.405 9.0205 -
Global Peer STRYKER CORP NYSE 77,002.986 36.967 48.097 6.0376 1.038
Global Peer BECTON DICKINSON & CO NYSE 64,953.846 60.031 83.920 2.7042 1.282
Global Peer BOSTON SCIENTIFIC CORP NYSE 53,421.218 11.366 13.422 3.4209 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 48,153.840 45.997 64.758 12.5429 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 41,070.269 31.443 36.861 3.3388 2.029
Other Global Peers BAXTER INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALCON AG (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), RESMED INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), Top Glove (SGX), HOLOGIC INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), TELEFLEX INC (NYSE), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), STERIS PLC (NYSE), PERKINELMER INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), QIAGEN NV (NYSE), WATERS CORP (NYSE), NOVOCURE LTD (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), COCHLEAR LTD (ASX), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), PENUMBRA INC (NYSE), MICROPORT (HKEx), TANDEM DIABETES CARE INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), BRUKER CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ICU MEDICAL INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), KANGJI MEDICAL (HKEx), INARI MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), AK MEDICAL (HKEx), STAAR SURGICAL CO (NASDAQ), NUVASIVE INC (NASDAQ), EBOS GROUP (ASX), SHOCKWAVE MEDICAL INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), PEIJIA-B (HKEx), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), OUTSET MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), CANTEL MEDICAL CORP (NYSE), ATRICURE INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), CAREDX INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), INMODE LTD (NASDAQ), NANO-X IMAGING LTD (NASDAQ), MESA LABORATORIES INC (NASDAQ), NANOSONICS LIMITED (ASX), CIRC (HKEx), ATRION CORP (NASDAQ), LIFETECH SCI (HKEx), CERUS CORP (NASDAQ), KDL MEDICAL (HKEx), GENMARK DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), CRYOLIFE INC (NYSE), LEMAITRE VASCULAR INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), SI BONE INC (NASDAQ), VAPOTHERM INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), INOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), ZYNEX INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), SURMODICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), Medtecs Intl (SGX), VIEWRAY INC (NASDAQ), AXOGEN INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANTARES PHARMA INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), YESTAR HEALTH (HKEx), SEASPINE HOLDINGS CORP (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), UG Healthcare (SGX), MCP INCOME OPPORTUNITIES TRUST (ASX), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), GOLDEN MEDITECH (HKEx), CUTERA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), CORMEDIX INC (NYSE American), REPRO MEDSYSTEMS INC (NASDAQ), PW MEDTECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), AROA BIOSURGERY LTD (ASX), IRADIMED CORP (NASDAQ), INVACARE CORP (NYSE), STEREOTAXIS INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), TELA BIO INC (NASDAQ), ALPHA PRO TECH (NYSE American), ACCURAY INCORPORATED (NASDAQ), DERMTECH INC (NASDAQ), MISONIX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SIENTRA INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), MODERN DENTAL (HKEx), SOLENO THERAPEUTICS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ZOSANO PHARMA CORP (NASDAQ), SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), DARIOHEALTH CORP (NASDAQ), VINCENT MED (HKEx), INTRICOM CORP (NASDAQ), RESPIRI LTD (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), PAVMED INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), BIOMERICA INC (NASDAQ), ELECTROMED INC (NYSE American), NEURONETICS INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), ROCKWELL MEDICAL INC (NASDAQ), CONFORMIS INC (NASDAQ), ELECTROCORE INC (NASDAQ), YUNNAN ENERGY (HKEx), ENLIVEX THERAPEUTICS LTD (NASDAQ), Biolidics (SGX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SDI LTD (ASX), DAXOR CORP (NYSE American), NEPHROS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), TITAN MEDICAL INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), COMPUMEDICS (ASX), NEOVASC INC (NASDAQ), APPLIED UV INC (NASDAQ), MICRO-X LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), IMPEDIMED LIMITED (ASX), KELFRED (HKEx), OPTISCAN IMAGING (ASX), SENSUS HEALTHCARE INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), RESONANCE HEALTH LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ONCOCYTE CORP (NYSE American), IMMUCELL CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), INCANNEX HEALTHCARE LTD (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), DIMERIX LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), Yunnan Energy (SGX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), MOTUS GI HOLDINGS INC (NASDAQ), CARDIEX LTD (ASX), LIFE HEALTHCARE (HKEx), LBT INNOVATIONS LTD (ASX), AVINGER INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), BIOLASE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), METALICITY LIMITED (ASX), CELSION CORPORATION (NASDAQ), CHF SOLUTIONS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), USCOM LTD (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), CYANOTECH CORP (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), PREDICTIVE ONCOLOGY INC (NASDAQ), ADHERIUM LIMITED (ASX), Annica (SGX), DIGIRAD CORP (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), LIANLUO SMART LIMITED (NASDAQ), STHAI (SET), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CANCER GENETICS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), NANOVIBRONIX INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), ANALYTICA (ASX), OBALON THERAPEUTICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), DORSAVI LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.770
+9.62 %
10 Days -+0.190
+2.21 %
20 Days -+0.010
+0.11 %
Medium Term Return 3 Months -+3.537
+67.59 %
6 Months 0.100+6.643
+317.02 %
1 Year 0.140+7.287
+500.81 %
Long Term Return 2 Years 0.225+6.987
+404.49 %
3 Years 0.380+7.837
+880.71 %
5 Years 0.735+8.109
+1337.97 %
Annualised Return Annualised --
+70.43 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.403 - 9.767 Change From 1 Year Low +7.367 % Change From 1 Year Low (%) +524.96
Change From 1 Year High -0.997 % Change From 1 Year High (%) -10.21
2 Years Range 1.403 - 9.767 Change From 2 Years Low +7.367 % Change From 2 Years Low (%) +524.96
Change From 2 Years High -0.997 % Change From 2 Years High (%) -10.21
5 Years Range 0.660 - 9.767 Change From 5 Years Low +8.110 % Change From 5 Years Low (%) +1228.39
Change From 5 Years High -0.997 % Change From 5 Years High (%) -10.21
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Established in 1991 with only one factory and three production lines, Top Glove has since grown by leaps and bounds to become the world's largest rubber glove manufacturer. It was listed on the Malaysian bourse, Bursa Saham Kuala Lumpur on 27 March 2001. In a short span of slightly more than a year, on 16 May 2002, Top Glove Corporation Berhad's listing was successfully promoted from the Second Board to the Main Market of the Kuala Lumpur Stock Exchange. Top Glove has a shareholder fund of RM1.09 billion or USD358 million with an annual turnover of about RM2.08 billion or USD682 million as at financial year ended 31 August 2010. It is also one of the component stocks of the FTSE Bursa Malaysia ("FBM") Mid 70 Index, FBM Top 100 Index and FBM Emas Index with a market capitalization of RM3.28 billion as at 30 March 2011.

IPO Performance

Listing Date 27 Mar 2001 Full Subscription Rate (x) -
No of Placement Shares (M) - No of Public Offer Shares (M) 7.51 Public Offer Subscription Rate (x) -
IPO Price (MYR) 2.700 First Day Close (MYR) 0.495 First Week Close (MYR) 0.398
Current vs IPO Price (%) +224.81 First Day Gain (%) -81.67 First Week Gain (%) -85.26

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Aug 2019 Part 1(2.73 MB)
Part 2(2.39 MB)
Part 3(2.33 MB)
Part 4(2.51 MB)
Annual Report 2018 Aug 2018 Part 1(2.52 MB)
Part 2(1.90 MB)
Part 3(0.17 MB)
Part 4(0.62 MB)
Annual Report 2017 Aug 2017 Part 1(0.59 MB)
Part 2(3.00 MB)
Part 3(1.65 MB)
Annual Report 2016 Aug 2016 Part 1(2.73 MB)
Part 2(2.70 MB)
Part 3(2.62 MB)
Annual Report 2015 Aug 2015 Part 1(2.78 MB)
Part 2(0.83 MB)
Annual Report 2014 Aug 2014 Part 1(2.59 MB)
Part 2(1.36 MB)
Annual Report 2013 Aug 2013 Part 1(2.76 MB)
Part 2(1.78 MB)
Annual Report 2012 Aug 2012 Part 1(2.78 MB)
Annual Report 2011 Aug 2011 Part 1(2.86 MB)
Annual Report 2010 Aug 2010 Part 1(2.97 MB)
Part 2(3.08 MB)
Annual Report 2009 Aug 2009 Part 1(1.95 MB)
Part 2(2.87 MB)
Annual Report 2008 Aug 2008 Part 1(3.46 MB)
Annual Report 2007 Aug 2007 Part 1(2.84 MB)
Part 2(1.69 MB)
Annual Report 2006 Aug 2006 Part 1(1.89 MB)
Annual Report 2005 Aug 2005 Part 1(0.49 MB)
Part 2(0.18 MB)
Part 3(1.92 MB)
Part 4(1.57 MB)
Part 5(0.65 MB)
Part 6(0.26 MB)
Part 7(0.32 MB)
Part 8(1.36 MB)
Part 9(1.38 MB)
Part 10(1.01 MB)
Annual Report 2004 Aug 2004 Part 1(1.35 MB)
Part 2(0.80 MB)
Part 3(0.50 MB)
Part 4(2.43 MB)
Part 5(1.35 MB)
Part 6(0.95 MB)
Part 7(1.41 MB)
Annual Report 2003 Aug 2003 Part 1(0.54 MB)
Part 2(0.50 MB)
Part 3(3.55 MB)
Part 4(0.53 MB)
Part 5(0.78 MB)
Part 6(0.86 MB)
Annual Report 2002 Aug 2002 Part 1(0.69 MB)
Part 2(0.51 MB)
Part 3(0.76 MB)
Part 4(0.41 MB)
Annual Report 2001 Aug 2001 Part 1(0.93 MB)
Part 2(0.31 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
28 Sep 2020 8.900 8.980 8.730 8.770 53,219,000 8.8348
25 Sep 2020 8.770 8.950 8.550 8.800 76,303,600 8.7768
24 Sep 2020 8.000 8.620 7.980 8.550 98,426,100 8.4140
23 Sep 2020 8.000 8.180 7.820 8.020 53,309,100 8.0244
22 Sep 2020 7.980 8.160 7.890 8.030 58,568,000 8.0259
21 Sep 2020 8.060 8.220 7.790 8.000 56,976,100 7.9663
18 Sep 2020 7.810 8.250 7.430 7.980 91,346,500 7.9864
17 Sep 2020 8.780 8.820 7.790 7.790 198,958,800 8.3802
15 Sep 2020 8.480 8.500 8.110 8.430 85,720,100 8.3622
14 Sep 2020 8.350 8.760 8.200 8.580 143,423,500 8.5222
11 Sep 2020 6.450 8.030 6.150 7.760 226,350,200 7.4177
10 Sep 2020 7.300 7.440 6.110 6.450 168,847,100 6.6458
09 Sep 2020 7.550 7.640 7.040 7.150 135,605,800 7.2427
08 Sep 2020 8.350 8.430 7.500 7.640 93,827,000 7.8442
07 Sep 2020 8.360 8.590 8.100 8.280 29,271,800 8.3246
04 Sep 2020 8.200 8.740 8.090 8.380 37,005,200 8.4603
03 Sep 2020 8.800 9.460 8.110 8.370 106,369,800 8.8317
02 Sep 2020 8.827 8.867 8.633 8.693 31,187,400 8.7387
01 Sep 2020 9.000 9.053 8.800 8.833 47,039,100 8.8717
28 Aug 2020 8.693 8.833 8.633 8.760 51,028,200 8.7347
27 Aug 2020 8.753 8.867 8.507 8.800 50,986,500 8.7420
26 Aug 2020 8.333 8.820 8.293 8.780 68,980,800 8.6201
Summary
Current 2 Weeks
(14 Sep 2020 to 28 Sep 2020)
8.350 8.980 7.430 8.770 916,250,800 -
Previous 2 Weeks
(28 Aug 2020 to 11 Sep 2020)
8.693 8.980 7.430 7.760 926,531,600 -
4 Weeks from
(29 Jul 2020 to 27 Aug 2020)
8.780 8.987 7.430 8.800 1,262,526,300 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.